within Pharmacolibrary.Drugs.N_NervousSystem.N04B_DopaminergicAgents.N04BD02_Rasagiline;

model Rasagiline
  extends Pharmacolibrary.Drugs.ATC.N.N04BD02;

  annotation (Documentation(
info       = "<html><body><table><tr><td>Drug:</td><td>N04BD02</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Rasagiline is a selective, irreversible monoamine oxidase-B (MAO-B) inhibitor used as monotherapy or as adjunct therapy to levodopa in the treatment of Parkinson's disease. It is approved for use in many countries, including the US and EU.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported in healthy adult volunteers following single oral administration.</p><h4>References</h4><ol><li><p>Bilal, R, et al., &amp; Tariq, S (2022). Rasagiline Pharmacokinetics in CYP1A2 Variant Healthy Smokers &amp; Non-smokers in Different Doses. <i>Pakistan journal of medical sciences</i> 38(3Part-I) 589–594. DOI:<a href=&quot;https://doi.org/10.12669/pjms.38.3.4940&quot;>10.12669/pjms.38.3.4940</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/35480532/&quot;>https://pubmed.ncbi.nlm.nih.gov/35480532</a></p></li><li><p>Lin, Y, et al., &amp; Deng, J (2013). Comparative single-dose pharmacokinetics of rasagiline in minipigs after oral dosing or transdermal administration via a newly developed patch. <i>Xenobiotica; the fate of foreign compounds in biological systems</i> 43(8) 705–710. DOI:<a href=&quot;https://doi.org/10.3109/00498254.2012.758396&quot;>10.3109/00498254.2012.758396</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/23339547/&quot;>https://pubmed.ncbi.nlm.nih.gov/23339547</a></p></li><li><p>Zhou, W, et al., &amp; Wang, M (2018). Pharmacokinetics, Pharmacodynamics, and Safety of Rasagiline Transdermal Patch: A Preliminary Study in Healthy Chinese Subjects. <i>Clinical drug investigation</i> 38(2) 125–133. DOI:<a href=&quot;https://doi.org/10.1007/s40261-017-0588-y&quot;>10.1007/s40261-017-0588-y</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/29159774/&quot;>https://pubmed.ncbi.nlm.nih.gov/29159774</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
end Rasagiline;
